An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer

Juan Carlos Montero(Centro de Investigación del Cáncer), Atanasio Pandiella(Complejo Hospitalario Universitario de Albacete)
Journal of Experimental & Clinical Cancer Research
August 9, 2023
10.1186/s13046-023-02784-0
Cited by 10

Related Papers

Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks
|Blood|2008|89
Effect of Multikinase Inhibitors on Caspase-Independent Cell Death and DNA Damage in HER2-Overexpressing Breast Cancer Cells
|JNCI Journal of the National Cancer Institute|2010|48
Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer
|Journal of Experimental & Clinical Cancer Research|2022|23
Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2
|Oncotarget|2015|19
Regulation of the prometastatic neuregulin–<scp>MMP</scp>13 axis by <scp>SRC</scp> family kinases: therapeutic implications
|Molecular Oncology|2017|9